- Home
- Cardiology
- MedX Weekly: Breakthroughs in STEMI Therapy, COVID-19 and more

2w3 min read
Medical Article
Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. Subcutaneous Therapy Enhances Early Heart Attack Intervention A Phase 3 trial has shown positive efficacy and safety results for a next-generation GPIIb/IIIa inhibitor designed for rapid, pre-hospital treatment of STEMI. Administered via
MedX Weekly: Breakthroughs in STEMI Therapy, COVID-19 and more
12092 Reached43 Comments
Similar Content

Woman presented with Fever of Unknown Origin
7725 Reached93 Comments19 Likes

How Physicians Should Manage Stress?
35294 Reached152 Comments203 Likes

Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes

Pregnant Woman with HIV-1 Infection
747 Reached1 Likes

Case of Pulmonary Embolism with Syncope
544 Reached4 Likes